Language selection

Search

Patent 2332749 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2332749
(54) English Title: IMMUNOSTIMULATING AND GROWTH-ENHANCING PREPARATIONS
(54) French Title: PREPARATIONS IMMUNOSTIMULANTES ET ACCELERATRICES DE CROISSANCE
Status: Deemed Abandoned and Beyond the Period of Reinstatement - Pending Response to Notice of Disregarded Communication
Bibliographic Data
(51) International Patent Classification (IPC):
  • A23K 10/16 (2016.01)
  • A23K 10/12 (2016.01)
  • C12N 1/06 (2006.01)
  • C12N 1/20 (2006.01)
(72) Inventors :
  • HOUDE, ROBERT (Canada)
(73) Owners :
  • NUTRIBIOS CORP.
(71) Applicants :
  • NUTRIBIOS CORP. (Canada)
(74) Agent: MARKS & CLERK
(74) Associate agent:
(45) Issued:
(22) Filed Date: 2001-01-26
(41) Open to Public Inspection: 2001-07-31
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
09/494,558 (United States of America) 2000-01-31

Abstracts

English Abstract


A process for obtaining a feed additive material in which a gram-positive
bacterium is utilized to effect incorporation and in-vivo modification of high
concentrations of nucleic acid material. The nucleic acid material is
recovered by
either part of the recovered cellular biomass after lysis or as a part of the
cellular
biomass after lysis concomitantly with the concentrated cell-free broth. The
lysed
isolated or unseparated biomass if useful for low level inclusion in animal
feeds.


Claims

Note: Claims are shown in the official language in which they were submitted.


4
THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A method of formulating a thermostable, growth-enhancing feed
formulation, comprising:
providing a source of gram-positive bacteria;
providing culture media containing at least one of yeast RNA,
oligonucleotides,
RNA precursors or derivatives of RNA selected from AMP, CMP, GMP, IMP, UMP,
adenine, cytosine, guanine, thymine, uracil, inosine, adenosine, cytidine,
guanosine,
uridine, thymidine, orotic acid and salts thereof;
fermenting said bacteria in said culture media to provide a cell-free broth
fraction and a cellular fraction;
recovering said cellular fraction;
disrupting cells in said cellular fraction; and
combining said cellular fraction with feed material to form a growth-enhancing
feed material.
2. The method as set forth in claim 1, wherein said bacteria are
selected from the group consisting of Lactobacillus casei ATCC 7469,
Micrococcus
luteus ATCC 4696.
3. The method as set forth in claim 1, wherein said RNA fractions
comprise at least one of concentrated yeast fractions, yeast extract material,
RNA
derivatives selected from AMP, GMP, IMP, UMP, adenine, uracil, inosine,
guanine and
orotic acid.
4. The method as set forth in claim 1, wherein said culture media includes
at least two of whey, whey permeate, soy peptone, cottonseed peptone, sodium
acetate, ammonium citrate, magnesium sulfate, manganese sulfate, cobalt
carbonate,
surfactants, cane molasses, beet molasses, potassium phosphate, copper
carbonate
and mixtures thereof.
5. The method as set forth in claim 1, wherein said formulation contains
between 0.02% and 0.2% dry basis by weight bacteria.

5
6. The method as set forth in claim 1, further including the step of
processing said bacterial cellular fraction by treatments selected from the
group
comprising: high pressure cellular disruption, bead milling and lysozyme
treatment.
7. The method as set forth in claim 1, further including the steps of
concentrating said broth fraction by evaporation and subsequently treating
said
bacterial fraction treated by a treatment selected from the group consisting
of high
pressure cellular disruption, bead milling or lysozyme treatment.
8. The method as set forth in claim 1, wherein said culture media has a pH
of between 6.0 and 8Ø
9. A method of formulating a thermostable, growth-enhancing feed
additive, comprising:
providing a source of gram-positive bacteria;
providing culture media containing yeast RNA, oligonucleotides, RNA
precursors or derivatives of RNA selected from AMP, GMP, IMP, UMP, adenine,
uracil,
inosine, uridine, thymine, guanine and orotic acid. The culture media includes
at least
two of whey, whey permeate, soy and or cottonseed peptones, sodium acetate,
ammonium citrate, magnesium sulfate, manganese sulfate, cobalt carbonate, Span
TM
surfactants, Tween R surfactants, cane and/or beet molasses, potassium
phosphate,
copper carbonate and mixtures thereof.
fermenting said bacteria in said culture media to provide a broth fraction and
a
bacterial cellular fraction; and
recovering said bacterial cellular fraction, subjecting to hydrolysis, and
combining resultant thermostable cellular fraction with feed material to form
a growth-
enhancing feed material.
10. The method as set forth in claim 9, wherein said bacteria include
Lactobacillus casei ATCC 7469, Micrococcus luteus ATCC 4696.
11. The method as set forth in claim 9, wherein said RNA compounds
comprise at least one of the following: concentrated yeast fractions, yeast
extract
material, RNA, oligonucleotides, RNA precursors or derivatives selected from
the

6
group comprising of AMP, GMP, IMP, UMP, adenine, uracil, inosine, uridine,
thymine,
guanine and orotic acid.
12. The method as set forth in claim 9, wherein said culture media includes
at least two of whey, whey permeate, soy and/or cottonseed peptones, sodium
acetate, ammonium citrate, magnesium sulfate, manganese sulfate, cobalt
carbonate,
Span TM surfactants, Tween R surfactants, cane and/or beet molasses, potassium
phosphate, copper carbonate and mixtures thereof.
13. The method as set forth in claim 9, wherein said final compounded feed
formulations contain from between 0.02 and 0.2% by weight of the thermostable
dry
bacterial product.
14. The method as set forth in claim 9, further including the step of
processing said bacterial cellular fraction by individual or combined
treatments selected
from the group comprising: high pressure cellular disruption, ultrasonic
disruption, bead
milling, autolysis, or lysozyme treatment.
15. The method as set forth in claim 9, further including the step of
concentrating said culture media by evaporation and subsequently treating said
concentrated media fraction by individual or combined treatments selected from
the
group comprising: high pressure cellular disruption, ultrasonic disruption,
bead milling,
autolysis or lysozyme treatment.
16. The method as set forth in claim 9, wherein said culture media has an
initial pH of between 6.0 and 8.0 after inoculation.
17. The method as set forth in claim 9, wherein said cellular fraction is
added to final animal feed in a dry form.
18. The method as set forth in claim 9, wherein said cellular fraction is
added to final animal feed in a wet form.

7
19. The method as set forth in claim 9, wherein RNA compounds are
present at the onset of cultivation.
20. The method as set forth in claim 9, wherein RNA compounds are added
after onset of cultivation.
21. The method as set forth in claim 9, wherein RNA compounds are added
continuously during cultivation.

Description

Note: Descriptions are shown in the official language in which they were submitted.


CA 02332749 2001-O1-26
IMMUNOSTIMULATING AND GROWTH-ENHANCING PREPARATIONS
The present invention relates to immunostimulating and growth-enhancing
thermostable preparations and more particularly, the present invention relates
to such
preparations for use in compounded feeds.
One aspect of the present invention is to provide a method of formulating a
thermostable, growth-enhancing feed formulation, comprising:
providing a source of gram-positive bacteria;
providing culture media containing at least one of yeast RNA,
oligonucleotides,
RNA precursors or derivatives of RNA selected from AMP, CMP, GMP, IMP, UMP,
adenine, cytosine, guanine, thymine, uracil, inosine, adenosine, cytidine,
guanosine,
uridine, thymidine, orotic acid and salts thereof;
fermenting the bacteria in the culture media to provide a cell-free broth
fraction
and a cellular fraction;
recovering the cellular fraction;
disrupting cells in the cellular fraction; and
combining the cellular fraction with feed material to form a growth-enhancing
feed material.
A further aspect of the present invention is to provide a method of
formulating a
thermostable, growth-enhancing feed additive, comprising:
providing a source of gram-positive bacteria;
providing culture media containing yeast RNA, oligonucleotides, RNA
precursors or derivatives of RNA selected from AMP, GMP, IMP, UMP, adenine,
uracil,
inosine, uridine, thymine, guanine and orotic acid. The culture media includes
at least
two of whey, whey permeate, soy and or cottonseed peptones, sodium acetate,
ammonium citrate, magnesium sulfate, manganese sulfate, cobalt carbonate,
SpanT"~
surfactants, Tween~ surfactants, cane and/or beet molasses, potassium
phosphate,
copper carbonate and mixtures thereof.
fermenting the bacteria in the culture media to provide a broth fraction and a
bacterial cellular fraction; and
recovering the bacterial cellular fraction, subjecting to hydrolysis, and
combining resultant thermostable cellular fraction with feed material to form
a growth
enhancing feed material.

CA 02332749 2001-O1-26
2
Figure 1 is a flowchart describing the process according to one embodiment of
the invention together with the two variant methods of post fermentation
processing.
In order to formulate an effective preparation for addition to feed material,
a
group of selected strains of gram-positive bacteria were grown in carbohydrate
based
culture media to provide inoculum cultures for subsequent production volumes.
In the
example, the bacteria include Lactobacillus casei and Micrococcus luteus. The
culture
media also contained high concentrations of defined RNA compounds of
fermentative
or synthetic origin, typical examples of which include yeast RNA,
oligonucleotides, RNA
precursors or derivatives of RNA selected from AMP, GMP, IMP, UMP, adenine,
uracil,
inosine, guanine and orotic acid. The culture media includes at least two of
whey, whey
permeate, soy peptone, sodium acetate, ammonium citrate, magnesium sulfate,
manganese sulfate, cobalt carbonate, SpanT"' surfactants, Tween~ surfactants,
cane
and/or beet molasses, potassium phosphate, copper carbonate and mixtures
thereof.
Cultivation may be from six to thirty-six hours.
Subsequent to inoculation preparation, the bacterial inoculum is added in
proportions ranging from between 1 and 20% v/v to production media in the form
of
carbohydrates, sources of nitrogen, minerals and defined RNA compounds of
fermentative or synthetic origin supra. Cultivation may be from twelve to
forty-eight
hours.
At this stage, the cells may be harvested by centrifugation or filtration, the
cells
disrupted by lysozyme reaction, mechanical reaction and/or autolytic reaction
standardized with carriers and dried. The so-formed additive may then be added
to
feed mixtures. As an alternate method, the whole culture slurry may be
concentrated
by known means, prior to lysozyme and/or mechanical and/or autolytic
treatment.
Further, high pressure cellular disruption, ultrasonic disruption, and/or bead
milling may
be employed as suitable alternatives or complements to the lysozyme treatment
and to
cell controlled autolysis..
The resulting slurry of any of the two methods is then standardized by
addition
of any or any combination of the following inert carriers: brewers spent
grains, distillers
spent grains, mineral clays, silica compounds, powdered grain fractions,
starches or

CA 02332749 2001-O1-26
3
dextrins. The resulting mixtures are dried by any of the known methods, such
as
freeze-drying, spray-drying, flash drying, drum drying or fluid bed drying.
Alternatively,
the liquid slurry comprising the bacterial product along with the
standardizing carrier
may be used in its liquid form. A small amount of flavoring agent may
optionally be
added.
Figure 1 illustrates the two reaction schemes in process flow diagram form.
The formulation contains between 0.02% and 0.2% by weight (dry basis) of the
thermostable standardized bacterial product.
Although embodiments of the invention have been described above, it is not
limited thereto and it will be apparent to those skilled in the art that
numerous
modifications form part of the present invention insofar as they do not depart
from the
spirit, nature and scope of the claimed and described invention.

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC assigned 2016-01-26
Inactive: IPC removed 2016-01-26
Inactive: IPC assigned 2016-01-26
Inactive: IPC assigned 2016-01-26
Inactive: IPC deactivated 2016-01-16
Inactive: IPC assigned 2016-01-01
Inactive: IPC expired 2016-01-01
Inactive: First IPC assigned 2016-01-01
Inactive: IPC assigned 2016-01-01
Application Not Reinstated by Deadline 2007-01-26
Time Limit for Reversal Expired 2007-01-26
Inactive: Abandon-RFE+Late fee unpaid-Correspondence sent 2006-01-26
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 2006-01-26
Inactive: Cover page published 2001-08-01
Application Published (Open to Public Inspection) 2001-07-31
Inactive: First IPC assigned 2001-03-22
Inactive: Filing certificate - No RFE (English) 2001-02-28
Filing Requirements Determined Compliant 2001-02-28
Letter Sent 2001-02-28
Application Received - Regular National 2001-02-27

Abandonment History

Abandonment Date Reason Reinstatement Date
2006-01-26

Maintenance Fee

The last payment was received on 2004-12-15

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Fee History

Fee Type Anniversary Year Due Date Paid Date
Application fee - standard 2001-01-26
Registration of a document 2001-01-26
MF (application, 2nd anniv.) - standard 02 2003-01-27 2003-01-27
MF (application, 3rd anniv.) - standard 03 2004-01-26 2004-01-21
MF (application, 4th anniv.) - standard 04 2005-01-26 2004-12-15
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
NUTRIBIOS CORP.
Past Owners on Record
ROBERT HOUDE
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Representative drawing 2001-07-31 1 9
Abstract 2001-01-26 1 12
Description 2001-01-26 3 120
Claims 2001-01-26 4 130
Drawings 2001-01-26 1 21
Cover Page 2001-07-31 1 35
Courtesy - Certificate of registration (related document(s)) 2001-02-28 1 113
Filing Certificate (English) 2001-02-28 1 162
Reminder of maintenance fee due 2002-09-30 1 109
Reminder - Request for Examination 2005-09-27 1 116
Courtesy - Abandonment Letter (Request for Examination) 2006-04-06 1 166
Courtesy - Abandonment Letter (Maintenance Fee) 2006-03-23 1 177